Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ghrelin receptor antagonists for the treatment of obesity described by AstraZeneca

May 6, 2009

Positive findings for QR-333 in diabetic peripheral neuropathy

May 6, 2009

Xoma completes enrollment in phase I XOMA-052 program for type 2 diabetes

May 6, 2009

Amylin and Lilly to develop diabetes pen device for once-weekly exenatide

May 5, 2009

Merck KGaA describes new glucokinase activators for prevention and treatment of diabetes

May 5, 2009

Tadalafil improves erectile dysfunction in patients with benign prostatic hyperplasia

May 5, 2009

Northfield receives complete response from FDA denying approval of PolyHeme BLA

May 4, 2009

GlaxoSmithKline claims glycogen phosphorylase inhibitors as antidiabetic agents

May 4, 2009

Enrollment completed in Rockwell Medical's phase IIb study of SFP in iron deficiency anemia

April 30, 2009

Roche claims novel glucocorticoid receptor antagonists as antidiabetic agents

April 30, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...